David John Echevarria, B.A., M.A., Ph.D.

Affiliations: 
2003 Psychology, Biopsychology; Neuroscience Specialty Stony Brook University, Stony Brook, NY, United States 
 2003-2004 Neuroscience University of Texas at Austin, Austin, Texas, U.S.A. 
 2004-2005 The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 
 2005- Psychology The University of Southern Mississippi, Hattiesburg, MS, United States 
Website:
http://zebrafishscience.com
Google:
"David Echevarria"
Mean distance: 24.01
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

de Abreu MS, Giacomini ACVV, Echevarria DJ, et al. (2018) Legal aspects of zebrafish neuropharmacology and neurotoxicology research. Regulatory Toxicology and Pharmacology : Rtp
Song C, Liu BP, Zhang YP, et al. (2017) Modeling consequences of prolonged strong unpredictable stress in zebrafish: Complex effects on behavior and physiology. Progress in Neuro-Psychopharmacology & Biological Psychiatry
Kysil EV, Meshalkina DA, Frick EE, et al. (2017) Comparative Analyses of Zebrafish Anxiety-Like Behavior Using Conflict-Based Novelty Tests. Zebrafish
Khan KM, Collier AD, Meshalkina DA, et al. (2017) Zebrafish models in neuropsychopharmacology and CNS drug discovery. British Journal of Pharmacology
Meshalkina DA, Kizlyuk M, Kisel E, et al. (2017) Zebrafish models of autism spectrum disorder. Experimental Neurology
Meshalkina DA, Kizlyk MN, Kysil EV, et al. (2016) Understanding zebrafish cognition. Behavioural Processes
Homberg JR, Kyzar EJ, Stewart AM, et al. (2015) Improving treatment of neurodevelopmental disorders: Recommendations based on preclinical studies. Expert Opinion On Drug Discovery
Kalueff AV, Echevarria DJ, Homechaudhuri S, et al. (2015) Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology research. Aquatic Toxicology (Amsterdam, Netherlands)
Stewart AM, Nguyen M, Poudel MK, et al. (2015) The failure of anxiolytic therapies in early clinical trials: what needs to be done. Expert Opinion On Investigational Drugs. 24: 543-56
Stewart AM, Grossman L, Collier AD, et al. (2015) Anxiogenic-like effects of chronic nicotine exposure in zebrafish. Pharmacology, Biochemistry, and Behavior
See more...